JPS5299222A - Medicines for aplastic anemia - Google Patents

Medicines for aplastic anemia

Info

Publication number
JPS5299222A
JPS5299222A JP1441876A JP1441876A JPS5299222A JP S5299222 A JPS5299222 A JP S5299222A JP 1441876 A JP1441876 A JP 1441876A JP 1441876 A JP1441876 A JP 1441876A JP S5299222 A JPS5299222 A JP S5299222A
Authority
JP
Japan
Prior art keywords
aplastic anemia
medicines
patients
enzyme
increase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1441876A
Other languages
Japanese (ja)
Other versions
JPS5938204B2 (en
Inventor
Hiroshi Tajima
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Priority to JP1441876A priority Critical patent/JPS5938204B2/en
Publication of JPS5299222A publication Critical patent/JPS5299222A/en
Publication of JPS5938204B2 publication Critical patent/JPS5938204B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE: Medicines containing co-enzyme Q as main component effective to increase the number of red corpuscles of patients of aplastic anemia.
COPYRIGHT: (C)1977,JPO&Japio
JP1441876A 1976-02-14 1976-02-14 Aplastic anemia treatment agent Expired JPS5938204B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1441876A JPS5938204B2 (en) 1976-02-14 1976-02-14 Aplastic anemia treatment agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1441876A JPS5938204B2 (en) 1976-02-14 1976-02-14 Aplastic anemia treatment agent

Publications (2)

Publication Number Publication Date
JPS5299222A true JPS5299222A (en) 1977-08-19
JPS5938204B2 JPS5938204B2 (en) 1984-09-14

Family

ID=11860461

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1441876A Expired JPS5938204B2 (en) 1976-02-14 1976-02-14 Aplastic anemia treatment agent

Country Status (1)

Country Link
JP (1) JPS5938204B2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146338A2 (en) * 1983-12-15 1985-06-26 Shiratori Pharmaceutical Co. Ltd. A blood accelerator 2, 3-diphosphoglyceric acid
WO2004066988A1 (en) * 2003-01-31 2004-08-12 Kaneka Corporation Fatigue reducing agent
WO2005107737A1 (en) 2004-05-11 2005-11-17 Kaneka Corporation Antifatigue composition
US7708990B2 (en) 2004-03-23 2010-05-04 Kaneka Corporation Coenzyme Q compositions persisting in blood
CN112933065A (en) * 2021-03-04 2021-06-11 中国科学院北京基因组研究所(国家生物信息中心) Application of coenzyme Q10 in preparation of medicine for relieving erythroid differentiation disorder

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0146338A2 (en) * 1983-12-15 1985-06-26 Shiratori Pharmaceutical Co. Ltd. A blood accelerator 2, 3-diphosphoglyceric acid
EP0146338A3 (en) * 1983-12-15 1985-11-21 Shiratori Pharmaceutical Co. Ltd. A blood accelerator 2, 3-diphosphoglyceric acid
WO2004066988A1 (en) * 2003-01-31 2004-08-12 Kaneka Corporation Fatigue reducing agent
US8946303B2 (en) 2003-01-31 2015-02-03 Kaneka Corporation Fatigue reducing agent
US7708990B2 (en) 2004-03-23 2010-05-04 Kaneka Corporation Coenzyme Q compositions persisting in blood
WO2005107737A1 (en) 2004-05-11 2005-11-17 Kaneka Corporation Antifatigue composition
CN112933065A (en) * 2021-03-04 2021-06-11 中国科学院北京基因组研究所(国家生物信息中心) Application of coenzyme Q10 in preparation of medicine for relieving erythroid differentiation disorder

Also Published As

Publication number Publication date
JPS5938204B2 (en) 1984-09-14

Similar Documents

Publication Publication Date Title
JPS5299220A (en) Medicines for bulbospinal paralysis
JPS5211823A (en) Digital display unit
JPS52108028A (en) Remedies for dysacousis
JPS5299222A (en) Medicines for aplastic anemia
JPS5228926A (en) Process for film coating of medicines
JPS51128255A (en) Analog-digital converter
JPS52128232A (en) Drugs for alleviating toxicity to kidneys
JPS51143633A (en) Process for preparation of novel epoxy compounds
JPS5273878A (en) Synthesis of 6-carboxyacetyl-3,4-dihydrocarbostyril
JPS525769A (en) Preparation of 3-substituted pyrolidine derivatives
JPS51117663A (en) Powdery-substance integer division unit
JPS5219652A (en) Preparation of leucylagmatine compounds
JPS5346937A (en) Preparation of n-p-aminobenzoyl-n,-p-aminourea
JPS525782A (en) Preparation of 1-phthalazinone
JPS5299221A (en) Medicines for alveolar ectasia
JPS5210490A (en) Preparation of 3-amino-1-(alpha-carboxy-4- hydroxybenzyl)-2-azetidinones
JPS5211842A (en) Data processing equipment
JPS5217465A (en) Preparation of 4-iodo-5-bromoindole-3- phosphates
JPS5346955A (en) Polyoxypregnane type compound
JPS52144631A (en) Inclusion composition, its preparation and separation of #-diethylbenzene from #-diethylbenzene-containing mixture
JPS5212195A (en) Preparation of 1,2,5-thiadiazolo(3,4-e)2, 7,1,3,6,8-dithiatetraza-as-in dacene
JPS53141240A (en) Novel threonine and allothreonine derivatives and preocess for their preparation
JPS52110816A (en) Medicines
JPS5271494A (en) Synthesis of triazolothienodiazrpins
JPS5328186A (en) Preparation of novel s-triazine compound